39 40 OBJECTIVES 41 42 In Malaysia, there is exponential growth of patients on dialysis. Dialysis treatment consumes 43 a considerable portion of healthcare expenditure. Comparative assessment of their cost 44 effectiveness can assist in providing a rational basis for preference of dialysis modalities. 45 46 METHODS 47 48 A cost utility study of hemodialysis (HD) and continuous ambulatory peritoneal dialysis 49 (CAPD) was conducted from a Ministry of Health (MOH) perspective. A Markov model was 50 also developed to investigate the cost effectiveness of increasing uptake of CAPD to 55% and 51 60 % versus current practice of 40% CAPD in a five-year temporal horizon. A scenario with 52 30% CAPD was also measured. The costs and utilities were sourced from published data which 53 were collected as part of this study. The transitional probabilities and survival estimates were 54 obtained from the Malaysia Dialysis and Transplant Registry (MDTR). The outcome measures 55 were cost per life year (LY), cost per quality adjusted LY (QALY) and incremental cost 56 effectiveness ratio (ICER) for the Markov model. Sensitivity analyses were performed. 57 58 RESULTS 59 60 LYs saved for HD was 4.15 years and 3.70 years for CAPD. QALYs saved for HD was 3.544 61 years and 3.348 for CAPD. Cost per LY saved was RM39,791 for HD and RM37,576 for 62 CAPD. The cost per QALY gained was RM46,595 for HD and RM41,527 for CAPD. The 63 Markov model showed commencement of CAPD in 50% of ESRD patients as initial dialysis 3 64 modality was very cost-effective versus current practice of 40% within MOH. Reduction in 65 CAPD use was associated with higher costs and a small devaluation in QALYs. 66 67 CONCLUSIONS 68 69
period. The rates were converted into an annual transition probability by using the following 176 formula; p = 1 -exp (-r*t) where p is the per cycle probability, r is the per-cycle rate, and t is 177 the number of cycles. Relevant model data were incorporated based on primary data which were collected as part of 214 this study and the detailed methodology and results have been published elsewhere [14, 15] .
216
Transition probabilities were estimated according to an analysis of a de-identified dataset from 217 MDTR as described above. The transition probabilities were assigned to each modality 218 including death. Three health states (HD, CAPD, Death) were defined, with the chance of 219 bidirectional transitions between all the states except death, which is an absorbent state. The 220 total of probability must add up to one in each scenario. The initial prevalence was distributed the patient may stay on their current modality, switch to a different modality or die. Patients patient dies, he/she no longer accrue costs and benefits. Table 1 shows the model inputs. distribution for costs and a beta distribution for utilities and transition probabilities were used.
246
Costs and outcomes were undiscounted or discounted at an annual rate of 3%. The result is 247 presented in a cost effectiveness acceptance curve (CEAC). 1.06 and 1.12 respectively (Table 3) . The annual death rate was higher in CAPD (0.134) than in HD (0.125). CAPD patients had a 300 higher rate of switching dialysis modality (0.067) than HD patients (0.007) (Table 4 ). QALYs. The base case scenario generated a higher undiscounted LYs (8.005) and QALYs 315 (7.113) but with a higher cost (RM313,412). The ICER did not exceeded cost effectiveness 316 threshold of three times GDP (RM120,000). However, the ICER exceeded the threshold for discounted costs and outcomes. Thus, scenario 2 appeared to be the most cost-effective 318 strategy. adjustments were not pursued in the current study to reflect the current situation in Malaysia.
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One-way sensitivity analysis
Hence, the unadjusted mortality rate was higher in PD than HD in the current Markov model. [39] .
440
The present study has several limitations. The lack of randomized controlled clinical trials 441 means the causality between dialysis modality and mortality cannot be determined. Training 
